The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Trans Genic Inc. engages in the development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Contract Research Organization (CRO), Diagnostic Analysis, and Trans Genic Business Service (TGBS). The CRO segment deals with clinical trials, pharmacological tests, pharmacokinetic tests, non-clinical trials, and the production of genetically modified mice. The Diagnostic Analysis segment provides pathological diagnosis, gene analysis, and drug discovery support services for personalized medicine. The TGBS segment offers advice and support services related to the promotion of new business through mergers and acquisitions, business succession, and business revitalization. The company was founded on April 21, 1998 and is headquartered in Kumamoto, Japan.

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

GemPharmatech is a high-tech biotechnology enterprise specializing in the research and development of humanized models and drug screening technologies. It has a leading disease model research and development ability and a genetic engineering mouse model creation center.In 2018, the company's "Humanization Model and Drug Screening Innovation Technology Research Institute" was absorbed by the Jiangsu Industrial Technology Research Institute as a "professional research institute", and became a new research and development institution that supports the establishment of an industrial chain and international development in this field. The company aims to provide global partners with one-stop innovative technologies and resource services such as model creation, breeding, mouse sales, phenotypic analysis, and functional efficacy.

Yuandaolong (Suzhou) Medical Technology Co., Ltd., established on 2013-04-18, Business scope includes research and development of biological and nanotechnology,Technology Transformation and Technology Transfer;Exhibition business service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. It operates through the following segments: Gene Editing Services, Pre-Clinical Pharmacology and Efficacy Evaluation, Animal Models Selling, Antibody Development, and Innovative Drugs Development. The Gene Editing Services segment provides gene editing services. The Pre-Clinical Pharmacology and Efficacy Evaluation segment involves in the provision of pre-clinical pharmacology service for drug efficacy and toxicity evaluation. The Animal Models Selling segment breeds and sells the animal models for the external and internal use. The Antibody Development segment includes one-stop solution from antibody preparation to IND filing for the customer. The Innovative Drugs Development consists of research and developing drugs with a focus on oncology and autoimmune disease therapeutics. The company was founded by Yue Lei Shen on November 13, 2009 and is headquartered in Beijing, China.

Central Institute for Experimental Animals (CIEA) (実験動物中央研究所) is a research center for experimental animals in Japan. It was founded by Tatsuji Nomura in 1952 with the mission of improving the level of biomedical research.

Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.

Merck Serono S.A. discovers, develops, manufactures, and commercializes prescription medicines focusing on various therapeutic areas that include oncology, immuno-oncology, immunology, multiple sclerosis, fertility, endocrinology, biosimilars, and neglected diseases. It develop treatments to help manage neurodegenerative diseases, such as multiple sclerosis; colorectal cancer; drugs to treat head and neck cancer; fertility drugs for every stage of the reproductive cycle.

Guangdong Yaokang Biotechnology Co., Ltd., established on 2018-10-26, Business scope includes general items:Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Experimental animal litter production;Experimental analysis instrument sales;Laboratory Animal Bedding Sales;Laboratory animal cage sales;Engineering and Technology Research and Experimental Development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Sales of Class I Medical Devices;Domestic trade agent;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;pharmaceutical production;Experimental animal production;Experimental animal management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

CIEMAT is a public research organization focused mainly on the research of energy, environment, and technological fields.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Hunan Zhaotai Biopharmaceutical Co., Ltd., established on 2017-03-08, Business scope includes research and development of biological products;Application of farming technology;Animal Husbandry Scientific Research Services;Agricultural Science Research and Experimental Development;Agricultural sales;Medical Research and Experimental Development;Biotechnology Development Services,consult,communication service,transfer service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanmo Bio is a life sciences firm with a focus on genetically modified model organisms, mainly for life science gene function and drugs R&D.

Guangdong Nanmo Biotechnology Co., Ltd., established on 2020-08-13, Business scope includes research and development:Biotechnology,Instrumentation;Technical extension services;Sales:Biological product,Instrumentation,laboratory equipment,Specialty Chemicals(Free of Hazardous Chemicals);Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(The above business scope involves the import and export of goods,Technology Import and Export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Toshi Biotechnology Co., Ltd., established on 2019-07-29, The scope of business includes engaging in biotechnology,Technology development in the professional field of instrumentation technology,technical consulting,Technical Services,technology transfer,Instrumentation,laboratory equipment,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)Sales,Engaged in the import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.]

Shenzhen Vivo Biomedical Technology Co., Ltd., established on 2014-06-25, Business scope includes general business items:Technology development of biopharmaceutical products,Import and export of goods and technology.,The licensing program is:Sales of biopharmaceutical products.